Literature DB >> 28158443

Body Mass Index and Amyotrophic Lateral Sclerosis: A Study of US Military Veterans.

Daniela Mariosa, John D Beard, David M Umbach, Rino Bellocco, Jean Keller, Tracy L Peters, Kelli D Allen, Weimin Ye, Dale P Sandler, Silke Schmidt, Fang Fang, Freya Kamel.   

Abstract

Amyotrophic lateral sclerosis (ALS) may be associated with low body mass index (BMI) at the time of diagnosis. However, the role of premorbid BMI in the development of ALS and survival after diagnosis remains unclear. In 2005-2010, we interviewed 467 patients with ALS from the US National Registry of Veterans with ALS and 975 frequency-matched veteran controls. In this sample, we evaluated the association of BMI and BMI change at different ages with ALS risk using unconditional logistic models and with survival after ALS diagnosis using Cox proportional hazards models. After adjustment for confounders, compared with a moderate increase in BMI between ages 25 and 40 years, stable or decreasing BMI was positively associated with ALS risk (odds ratio (OR) = 1.61, 95% confidence interval (CI): 1.20, 2.16). A 1-unit increase in BMI at age 40 years (OR = 0.95, 95% CI: 0.91, 0.98) but not at age 25 years (OR = 0.99, 95% CI: 0.95, 1.03) was inversely associated with ALS. These associations were similar for bulbar and spinal ALS but stronger for those with a delay of less than 1 year between symptom onset and diagnosis. We found no association between prediagnosis BMI and survival. A decreasing BMI from early to middle age and a low BMI in middle age may be positively associated with ALS risk. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  United States; amyotrophic lateral sclerosis; body mass index; body weight changes

Mesh:

Year:  2017        PMID: 28158443      PMCID: PMC5860019          DOI: 10.1093/aje/kww140

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  43 in total

1.  Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicenter study in Japan.

Authors:  Toshio Shimizu; Utako Nagaoka; Yuki Nakayama; Akihiro Kawata; Chiharu Kugimoto; Yoshiyuki Kuroiwa; Mitsuru Kawai; Takayoshi Shimohata; Masatoyo Nishizawa; Ban Mihara; Hajime Arahata; Naoki Fujii; Reiko Namba; Hiroaki Ito; Takashi Imai; Keigo Nobukuni; Kiyohiko Kondo; Mieko Ogino; Takashi Nakajima; Tetsuo Komori
Journal:  Amyotroph Lateral Scler       Date:  2012-06

2.  Body mass index delineates ALS from FTD: implications for metabolic health.

Authors:  R M Ahmed; E Mioshi; J Caga; M Shibata; M Zoing; L Bartley; O Piguet; J R Hodges; M C Kiernan
Journal:  J Neurol       Date:  2014-06-24       Impact factor: 4.849

3.  BMI trends, socioeconomic status, and the choice of dataset.

Authors:  Michael Grabner
Journal:  Obes Facts       Date:  2012-03-02       Impact factor: 3.942

4.  Nutritional status is a prognostic factor for survival in ALS patients.

Authors:  J C Desport; P M Preux; T C Truong; J M Vallat; D Sautereau; P Couratier
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

5.  Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011.

Authors:  Kim Traxinger; Crystal Kelly; Brent A Johnson; Robert H Lyles; Jonathan D Glass
Journal:  Neurol Clin Pract       Date:  2013-08

6.  Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways.

Authors:  Tao Wang; Xin Jiang; Gang Chen; Jin Xu
Journal:  Neurobiol Aging       Date:  2014-08-04       Impact factor: 4.673

Review 7.  Body mass index and dietary intervention: implications for prognosis of amyotrophic lateral sclerosis.

Authors:  S T Ngo; F J Steyn; P A McCombe
Journal:  J Neurol Sci       Date:  2014-03-03       Impact factor: 3.181

8.  Amyotrophic lateral sclerosis is associated with hypolipidemia at the presymptomatic stage in mice.

Authors:  Sung-Min Kim; Heejaung Kim; Jee-Eun Kim; Kyung Seok Park; Jung-Joon Sung; Seung Hyun Kim; Kwang-Woo Lee
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

Review 9.  Risk factors for amyotrophic lateral sclerosis.

Authors:  Caroline Ingre; Per M Roos; Fredrik Piehl; Freya Kamel; Fang Fang
Journal:  Clin Epidemiol       Date:  2015-02-12       Impact factor: 4.790

10.  Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort.

Authors:  Valentina Gallo; Petra A Wark; Mazda Jenab; Neil Pearce; Carol Brayne; Roel Vermeulen; Peter M Andersen; Goran Hallmans; Andreas Kyrozis; Nicola Vanacore; Mariam Vahdaninia; Verena Grote; Rudolf Kaaks; Amalia Mattiello; H Bas Bueno-de-Mesquita; Petra H Peeters; Ruth C Travis; Jesper Petersson; Oskar Hansson; Larraitz Arriola; Juan-Manuel Jimenez-Martin; Anne Tjønneland; Jytte Halkjær; Claudia Agnoli; Carlotta Sacerdote; Catalina Bonet; Antonia Trichopoulou; Diana Gavrila; Kim Overvad; Elisabete Weiderpass; Domenico Palli; J Ramón Quirós; Rosario Tumino; Kay-Tee Khaw; Nicholas Wareham; Aurelio Barricante-Gurrea; Veronika Fedirko; Pietro Ferrari; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Heiner Boeing; Matthaeus Vigl; Lefkos Middleton; Elio Riboli; Paolo Vineis
Journal:  Neurology       Date:  2013-02-06       Impact factor: 9.910

View more
  12 in total

1.  Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis.

Authors:  Hiroshi Mitsumoto; Diana C Garofalo; Regina M Santella; Eric J Sorenson; Björn Oskarsson; J Americo M Fernandes; Howard Andrews; Jonathan Hupf; Madison Gilmore; Daragh Heitzman; Richard S Bedlack; Jonathan S Katz; Richard J Barohn; Edward J Kasarskis; Catherine Lomen-Hoerth; Tahseen Mozaffar; Sharon P Nations; Andrea J Swenson; Pam Factor-Litvak
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2020-04-10       Impact factor: 4.092

Review 2.  Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis.

Authors:  Andrew T Nelson; Davide Trotti
Journal:  Neurotherapeutics       Date:  2022-06-30       Impact factor: 6.088

Review 3.  Lipid Metabolic Alterations in the ALS-FTD Spectrum of Disorders.

Authors:  Juan Miguel Godoy-Corchuelo; Luis C Fernández-Beltrán; Zeinab Ali; María J Gil-Moreno; Juan I López-Carbonero; Antonio Guerrero-Sola; Angélica Larrad-Sainz; Jorge Matias-Guiu; Jordi A Matias-Guiu; Thomas J Cunningham; Silvia Corrochano
Journal:  Biomedicines       Date:  2022-05-10

4.  Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia.

Authors:  Raphael Simon Peter; Angela Rosenbohm; Luc Dupuis; Torben Brehme; Jan Kassubek; Dietrich Rothenbacher; Gabriele Nagel; Albert Christian Ludolph
Journal:  Eur J Epidemiol       Date:  2017-10-03       Impact factor: 8.082

Review 5.  Body mass index and survival from amyotrophic lateral sclerosis: A meta-analysis.

Authors:  Efthimios Dardiotis; Vasileios Siokas; Maria Sokratous; Zisis Tsouris; Athina-Maria Aloizou; Desponia Florou; Metaxia Dastamani; Alexios-Fotios A Mentis; Alexandros G Brotis
Journal:  Neurol Clin Pract       Date:  2018-10

6.  Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study.

Authors:  Ikjae Lee; Mohamed Kazamel; Tarrant McPherson; Jeremy McAdam; Marcas Bamman; Amy Amara; Daniel L Smith; Peter H King
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

7.  Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders.

Authors:  Estela Area-Gomez; H Mitsumoto; D Larrea; T Yun; Y Xu; J Hupf; F Zandkarimi; R B Chan
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

Review 8.  Disease-modifying effects of metabolic perturbations in ALS/FTLD.

Authors:  Ali Jawaid; Romesa Khan; Magdalini Polymenidou; Paul E Schulz
Journal:  Mol Neurodegener       Date:  2018-12-04       Impact factor: 14.195

Review 9.  The effects of diet and sex in amyotrophic lateral sclerosis.

Authors:  J A Pape; J H Grose
Journal:  Rev Neurol (Paris)       Date:  2020-03-05       Impact factor: 2.607

10.  Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients.

Authors:  David Bayer; Stefano Antonucci; Hans-Peter Müller; Rami Saad; Luc Dupuis; Volker Rasche; Tobias M Böckers; Albert C Ludolph; Jan Kassubek; Francesco Roselli
Journal:  Transl Neurodegener       Date:  2021-05-31       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.